Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Gabapentin NDC 71610-188 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

71610 0188 98

71610 0188 98

Aphena Pharma Solutions - TN - Aphena

Aphena Pharma Solutions - TN - Aphena

Formula - gabapentin fig1

Formula - gabapentin fig1

This text seems to be part of a mathematical formula used to calculate something related to creatinine levels and weight of patients aged 140 years and above. Unfortunately, without additional context or information, it is difficult to determine the specific calculation being made or the purpose behind it.*

Figure 1 - gabapentin fig2

Figure 1 - gabapentin fig2

Figure 2 - gabapentin fig3

Figure 2 - gabapentin fig3

This appears to be a chart displaying mean pain scores for a study with a 3-week dose titration period, followed by a 4-week fixed dose period. The chart appears to compare the effectiveness of a placebo versus two different doses of Gabapentin (1800mg/day and 2400mg/day) on pain reduction. The "Baseline" section of the chart may represent initial pain scores before any treatment was given.*

Figure 3 - gabapentin fig4

Figure 3 - gabapentin fig4

The text is a table presenting the proportion of responders (patients with ≥ 50% reduction in pain score) in controlled PHN studies. The table includes data for two studies with the percentage of responders for each treatment group (placebo, GBP 3600, GBP 1800, GBP 2400), at the endpoint. Additionally, the table has two statistical values, #p<001 and 5D < 0.001, but there is not enough context to interpret their meanings.*

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Chemical Structure - gabapentin str

Chemical Structure - gabapentin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.